 |
osimertinib |
|---|---|
| Trade Name | Tagrisso |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2014-09-04 00:00:00 |
| Sponsor | AstraZeneca Pharmaceuticals LP;P. O. Box 8355, 1800 Concord Pike;Wilmington, Delaware, 19803 |
Related Access Program